ITM to Host Theranostics Symposium on Clinical Need and Supply at SNMMI Annual Meeting on ...

Garching / Munich, June 15, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a multidisciplinary symposium titled, “ Investing

Related Keywords

New Jersey ,United States ,Germany ,Munich ,Bayern ,Canada ,German ,Canadian ,Julia Hofmann Svenja ,Ram Mullur ,Harshad Kulkarni ,Neil Quigley ,Radiomolecular Theranostics ,Steffen Schuster ,Roger Estafanos ,Ben Orzelek ,Technology Perspective ,Canadian Nuclear Laboratories ,German Society Of Nuclear Medicine ,Theranostics Center ,Corporate Communications ,Novartis ,Chief Medical Advisor ,Bold Advanced Medical Future ,Global Product Manager ,Vice President ,Canadian Nuclear ,Speaker Details ,Advanced Accelerator Applications ,Clinical Perspective ,Future Utilization ,Grand Rapids ,Precision Oncology ,Zentralklinik Bad Berka ,Radiochemical Perspective ,Synergy Between ,George Von Hevesy Prize ,German Society ,Nuclear Medicine ,Commercial Availability ,Radionuclide Therapy ,Technologies Munich ,